Are you a student? http://femjoy.in.net/ femjoyhunter  Chris Viehbacher told an investor conference the group hadthe resources to do "opportunistic" share buybacks, as well asmaking bolt-on acquisitions and potentially increasing its stakein U.S. biotech firm Regeneron Pharmaceuticals.